Fingerprint
Dive into the research topics of 'Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
Jean Pierre F. Issa, Vazganush Gharibyan, Jorge Cortes, Jaroslav Jelinek, Gail Morris, Srdan Verstovsek, Moshe Talpaz, Guillermo Garcia-Manero, Hagop M. Kantarjian
Research output: Contribution to journal › Article › peer-review
276
Scopus
citations